These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16464762)

  • 1. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
    Johnston KL; Farnen JP; Manske BR; Go RS
    Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.
    Shin HJ; Chung JS; Song MK; Kim SK; Choe S; Cho GJ
    Cancer Chemother Pharmacol; 2012 May; 69(5):1165-72. PubMed ID: 22215473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
    Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
    Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutropenic fever following chemotherapy in a patient with lymphoma.
    Book L
    Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegfilgrastim-induced pain in patients with lymphoma.
    Mullen EC
    Oncol Nurs Forum; 2014 Mar; 41(2):212-4. PubMed ID: 24578081
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma.
    Matsuo T; Tanaka T; Yano T
    J Clin Exp Hematop; 2018 Dec; 58(4):180-183. PubMed ID: 30416173
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim.
    Kang KW; Lee BH; Jeon MJ; Yu ES; Kim DS; Lee SR; Sung HJ; Choi CW; Park Y; Kim BS
    Cancer Med; 2020 Sep; 9(17):6102-6110. PubMed ID: 32633471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hope for very elderly patients with diffuse large B-cell lymphoma.
    Ribera JM
    Lancet Oncol; 2011 May; 12(5):412-3. PubMed ID: 21482185
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
    Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
    Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated diffuse large B cell lymphoma of bone on PET scan.
    Chen WL; Ho CL
    Int J Hematol; 2008 Jul; 88(1):1-2. PubMed ID: 18478313
    [No Abstract]   [Full Text] [Related]  

  • 13. Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.
    Wieringa A; Boslooper K; Hoogendoorn M; Joosten P; Beerden T; Storm H; Kibbelaar RE; Veldhuis GJ; van Kamp H; van Rees B; Kluin-Nelemans HC; Veeger NJ; van Roon EN
    Br J Haematol; 2014 May; 165(4):489-96. PubMed ID: 24754632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.
    Bozzoli V; Tisi MC; Maiolo E; Alma E; Bellesi S; D'Alo' F; Voso MT; Leone G; Hohaus S
    Br J Haematol; 2015 Jun; 169(6):787-94. PubMed ID: 25819007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.
    Case DC; Desch CE; Kalman LA; Vongkovit P; Mena RR; Fridman M; Allen B
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):354-60. PubMed ID: 17562245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic findings of intracardiac mass.
    Tanaka H; Kawai H; Ishida T; Yoshida A; Yokoyama M
    J Cardiol; 2007 Aug; 50(2):155-7. PubMed ID: 17802700
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.
    Rigacci L; Nassi L; Alterini R; Carrai V; Longo G; Bernardi F; Martini V; Bosi A
    Acta Haematol; 2006; 115(1-2):22-7. PubMed ID: 16424645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.
    Kang HJ; Kim WS; Suh C; Park YH; Kim BS; Yuh YJ; Ryoo BY
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):299-304. PubMed ID: 17922274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.